Jean Terrier, Frédéric Gaspar, Pauline Gosselin, Olivier Raboud, Camille Lenoir, Victoria Rollason, . . . for the OptimAT study group. (2023). Apixaban and rivaroxaban's physiologically‐based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side. Wiley.
Chicago Style (17th ed.) CitationJean Terrier, et al. Apixaban and Rivaroxaban's Physiologically‐based Pharmacokinetic Model Validation in Hospitalized Patients: A First Step for Larger Use of a Priori Modeling Approach at Bed Side. Wiley, 2023.
MLA (9th ed.) CitationJean Terrier, et al. Apixaban and Rivaroxaban's Physiologically‐based Pharmacokinetic Model Validation in Hospitalized Patients: A First Step for Larger Use of a Priori Modeling Approach at Bed Side. Wiley, 2023.